WASHINGTON, Jan 18 (Reuters) – Mallinckrodt Plc has
agreed to pay $100 million to settle allegations that a
subsidiary broke U.S. antitrust law by sharply increasing the
price of a multiple sclerosis…
The post UPDATE 2-Mallinckrodt to pay $100 mln to settle U.S. probe on drug pricing appeared first on NASDAQ.